Gen XY Updates from GlobeNewswire
2026-01-16T21:45:00Z
CHASKA, Minn., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on January 14, 2026,...
2026-01-16T21:30:00Z
HONG KONG, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over the counter (“OTC”) pharmaceutical cross-border e-commerce supply chain services...
2026-01-16T21:30:00Z
Jakarta, Jan. 16, 2026 (GLOBE NEWSWIRE) -- NusaTrip Incorporated (Nasdaq: NUTR) (“NusaTrip,” “NUTR,” or the “Company”), a travel ecosystem with geographical specialization in Southeast Asia and Asia-Pacific, today announced that...
2026-01-16T21:15:00Z
WALTHAM, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development...
2026-01-16T21:05:00Z
CAMBRIDGE, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate...
2026-01-16T21:05:00Z
PHILADELPHIA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today...
2026-01-16T21:05:00Z
VANCOUVER, British Columbia and BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing...
2026-01-16T21:04:00Z
Insider Access, Transformative Experiences and Free Packing Guide for African Safari Travelers
2026-01-16T21:01:00Z
Company to host conference call and webcast on Tuesday, January 20, 2026 at 8:00 am ET / 5:00 am PT
2026-01-16T19:45:30Z
BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the...
2026-01-16T19:19:57Z
MELBOURNE, Australia, Jan. 17, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed...
2026-01-16T18:30:00Z
Company Announcement
2026-01-16T17:12:40Z
American Heart Association consortium advances development of evidence-based health tech solutions
2026-01-16T17:00:00Z
Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ianalumab for Sjögren’s disease, the second most prevalent rheumatic...
2026-01-16T15:57:49Z
The Great American Food Chain, Inc. Announces Execution of Memorandum of Understanding with Green Matter BioTech
2026-01-16T15:50:17Z
Company joins forces with Genomic Answers for Children’s Health Alliance to clarify genomic sequencing as covered under Medicaid’s “Early and Periodic Screening, Diagnostic, and Treatment Services”
2026-01-16T14:00:00Z
Proposed marketing partnership aligns with Company’s broader expansion into event-based markets
2026-01-16T14:00:00Z
MINNEAPOLIS, Jan. 16, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced that this month it has successfully delivered an...
2026-01-16T13:30:00Z
HOUSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Glow Holdings, Inc. (OTC: GLOH), doing business as GlohCo, today announced its transition into a healthtech-focused public company following a corporate reset completed...
2026-01-16T13:30:00Z
NORTH PALM BEACH, Fla., Jan. 16, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced that it has invested in the common stock of...
2026-01-16T13:30:00Z
PALI-2108 Abstracts Highlight Gut-Targeted PDE4B Inhibition and Translational Phase 1a Findings in Ulcerative Colitis
2026-01-16T13:30:00Z
SALT LAKE CITY, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company...
2026-01-16T13:15:00Z
TORONTO, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today the appointment of Dr. Patrick Vink as Chairman...
2026-01-16T13:00:00Z
Governance evolution follows elimination of major convertible debt, recent funding, and improved capital structure
2026-01-16T13:00:00Z
BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of...
2026-01-16T13:00:00Z
MARKHAM, Ontario, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the fourth quarter...
2026-01-16T13:00:00Z
In 2025, Forever Network delivered more than 20 billion impressions across its platforms to 450 million people
2026-01-16T13:00:00Z
LITTLETON, Colo., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (Nasdaq: VVOS), a leading medical device and healthcare services company focused on sleep related breathing...
2026-01-16T13:00:00Z
POMPANO BEACH, Fla., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced the commercial availability of the Freedom® PNS...
2026-01-16T12:30:00Z
LOUISVILLE, K.Y., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Sun Pharmaceuticals for UNLOXCYT™ (cosibelimab-ipdl). UNLOXCYT...
2026-01-16T12:30:00Z
Research-use-only offerings are commercially available, enabling immediate product and service revenue generation
2026-01-16T12:03:00Z
WILMINGTON, Del., Jan. 16, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) (the “Company”), a clinical-stage biopharmaceutical company, today announced that it will hold its annual meeting of stockholders (the...
2026-01-16T12:00:00Z
NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable...
2026-01-16T12:00:00Z
WATERTOWN, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal...
2026-01-16T12:00:00Z
NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) today announced that it has entered into a 90-day lock-up agreement with SOL Markets (the “Strategic Advisor”),...
2026-01-16T12:00:00Z
BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces...
2026-01-16T10:00:00Z
Hamburg / Lommel, 16 January 2026 – Aqua free Industries, a specialist in membrane filters and bespoke OEM solutions within the Aqua free Group, is expanding its range to include...
2026-01-16T10:00:00Z
BASEL, Switzerland – January 16, 2026 – Nouscom, a clinical-stage biotech company developing next-generation immunotherapies to treat cancer at all stages, from early cancer interception to late-stage metastatic disease, today...
2026-01-16T07:30:00Z
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 16 JANUARY 2026 at 9:30 EET
2026-01-16T06:00:02Z
PALO ALTO, Calif., Jan. 15, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (the “Company,” “we” or “BridgeBio”), a new type of biopharmaceutical company focused on genetic diseases, announced...
2026-01-16T01:22:25Z
NeuroXen Editorial Report: "Strongest Adderall Alternative" Reflects Consumer Search Language in 2026 and Does Not Indicate Ranking, Endorsement, Equivalence to Adderall, or Product Effectiveness
2026-01-15T22:29:06Z
Phen24 Editorial Report: OTC Appetite Suppressants, Natural Weight Loss Pills, Prescription vs Supplement Standards, and the 7-Point Consumer Verification Framework
2026-01-15T22:10:48Z
Etan Bendheim assumes role of CEO and Mark Warner moves to CTO role
2026-01-15T21:30:00Z
HUNTSVILLE, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American: SER), a clinical-stage biotechnology company advancing its lead Investigational New Drug ("IND") candidate, SER-252, for...
2026-01-15T21:05:00Z
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel...
2026-01-15T21:03:00Z
IRVINE, Calif., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to...
2026-01-15T21:01:00Z
All resolutions passed, enabling the Company to streamline regulatory and operational processes
2026-01-15T19:30:00Z
GRAND PRAIRIE, Texas, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Greenhouse Treatment Center, a leading addiction rehab center in Dallas has added a new Harvard-trained physician, Dr. Queeneth Uwandu, MD, to its...
2026-01-15T18:50:59Z
Independent Research Examines Nano Microneedle Technology, Bioavailability Science, and Consumer Evaluation Criteria for Transdermal NAD+ and Berberine Formats
2026-01-15T18:39:44Z
New York City, NY, Jan. 15, 2026 (GLOBE NEWSWIRE) -- As metabolism supplements continue to grow in popularity in 2026, many consumers are seeking clear, factual information to better understand...
